>US Stocks>Aclaris Therapeutics

Aclaris TherapeuticsHealthcare

$4.01+$1.71 (+74.13%)in 1 year

As on 13 Nov 2026 at 02:29NASDAQ

52 Week Low: $2.1052 Week High: $6.60

Aclaris Therapeutics Share Price Today

Aclaris Therapeutics opened lower at $4.29, compared with its previous close of $4.34. In the last trading session, the stock traded between $4.00 and $4.33. It showed a downward intraday trend.

Return calculator

You have invested

Time Period

An investment of $100 made 5 years ago in Aclaris Therapeutics is now worth

$ 26.26

Resulting in a loss of

$ 73.74 (73.74%)

Invest with $1

Note: Past profits do not guarantee future returns.

Analyst Overview

Rating from 7 Analysts

Buy

100%

Hold

Sell

Markets Today

Today's Change

$-0.34 (-7.72%)

Day High

$4.33

Day Low

$4.00

Day Open

$4.29

Prev Close

$4.34

Volume

15,05,457

1W Return

8.98%

1M Return

11.40%

3M Return

-32.29%

6M Return

-19.09%

1Y Return

74.13%

Fundamentals

Market Cap ($ Mn)

635

PE Ratio

PB Ratio

6.75

PEG Ratio

ROE

-49.59%

ROCE

-44.83%

EPS (TTM)

$-0.12

Investment Returns

1 Week

8.98%

1 Month

11.40%

3 Months

-32.29%

6 Months

-19.09%

9 Months

18.14%

Financials

Quarterly

All values in $ Mn

1.5

Mar 25

1.8

Jun 25

3.3

Sep 25

1.3

Dec 25

1.6

Jun 26

1.5

Sep 26

Updates

5Nov

Aclaris Therapeutics Q3 Results: Loss narrows to $0.12 per share

Aclaris Therapeutics reported a Q3 loss of $0.12 per share, beating estimates by 25%. Quarterly sales fell 55.11% YoY to $1.481 million. The reported EPS loss was unchanged from the same period last year.

7 days ago

7Aug

Aclaris Therapeutics secures FDA Fast Track for modzatinib in lichen planus

Aclaris Therapeutics has secured FDA Fast Track designation for modzatinib for moderate to severe lichen planus, accelerating its development pathway. With no approved therapies currently available, the company aims to initiate a Phase 2b trial in Q4 2026 to gather critical safety and efficacy data.

3mo ago

Similar Stocks

Stock	LTP	Change %	Market Cap	PE
V Vertex Pharmaceuticals	$547.03	-0.16%	$1,38,692.89M	31.55
B British American Tobacco	$61.05	+0.38%	$1,31,510.31M	14.39
M Moderna	$248.69	-0.85%	$1,00,625.20M	-
R Regeneron Pharmaceuticals	$959.41	+4.73%	$97,505.80M	19.64
A Argen X SE - ADR	$977.58	+0.62%	$61,476.10M	38.99
O BeOne Medicines - ADR	$419.98	-0.95%	$46,108.31M	65.60
R Revolution Medicines	$180.70	-6.40%	$39,083.96M	-
G Genmab	$53.87	-0.37%	$33,618.11M	26.24
R Royalty Pharma - Class A	$70.01	+0.81%	$31,173.07M	32.37
R Roivant Sciences	$41.85	+1.60%	$30,322.88M	-
I Insmed	$120.75	+1.05%	$26,490.14M	-
I Incyte	$122.27	+1.64%	$24,922.54M	15.85